Compare Abeona Therapeutics Inc (ABEO) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs AT&T Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while AT&T Inc. trades at $24.4 (market cap $167.88B). The key difference: AT&T Inc. is far larger — about 398.6× Abeona Therapeutics Inc's market cap, and AT&T Inc. pays a 4.53% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | T | |
|---|---|---|
Market Cap | $421.19M | $167.88B |
Sector | Health | Media |
52-Week High | $7.45 | $29.62 |
52-Week Low | $4.17 | $20.49 |
Enterprise Value | $276.10M | $313.20B |
Dividend Yield | — | 4.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
